Shares of Applied DNA Sciences Inc. (OTC: APDN), a provider of botanical DNA-based security and authentication solutions that can help protect products, brands and intellectual property of companies, governments, and consumers, surged in trading today.
APDN shares ended the day 60.88% higher at $0.110 on above average volume of 8.57 million. The stock gained more than 93% in the last three trading sessions.
Earlier this week, APDN announced its third-quarter financial results. For the quarter ended June 30, 2012, APDN reported revenue of $528,574, representing an increase of 130% over the same period in the previous year.
Net loss for the third quarter fell 34% on a year-over-year basis.
Dr. James A. Hayward, President and CEO of Applied DNA Sciences, said that APDN continues to improve quarter over quarter beginning FYâ€™12 with an exciting first quarter and improving on that performance with each quarter to date.
Shares of Hollund Industrial Marine Inc. (PINK: HIMR), a provider of an integrated business model for underwater forest management, surged in trading today.
HIMR shares ended the day 22.22% higher at $0.0011 on above average volume of 118.09 million. HIMR shares gained 120% for the week.
HIMR this week announced that it is preparing to host its first shareholder conference call. The company plans to hold the conference call on Friday, September 28th, 2012.
Peter Meier, President of Hollund Industrial Marine, said that HIMR cannot envision any better way to complete the third quarter and begin what should prove to be an explosive fourth quarter, than with a conference call meant to give shareholders greater insight into the companyâ€™s decisions, growing operations and pending opportunities.
Shares of Organovo Holdings Inc. (PINK: ONVO), developer of NovoGen three-dimensional (3D) human tissue printing technology for creating tissue on demand for research and surgical applications, fell in trading today.
ONVO shares ended the day 2.25% lower at $2.17 on volume of 268,985. Despite the losses today, ONVO rose 3.33% for the week.
Earlier this week, Organovo reported its second-quarter financial results. For the quarter ended June 30, 2012, the company reported total revenue of $259,000, compared to $173,300 reported for the same period in the previous year.